| abstract |
[PROBLEMS] To develop pharmaceuticals, functional foods, and the like that exhibit safer and more effective angiotensin I converting enzyme inhibitory action. Angiotensin I containing, as an active ingredient, one or more dipeptides selected from the group consisting of cysteinyl glycine, tyrosinyl isoleucine, phenylalanyl methionine, 2-aminobutyric acid-phenylalanine and histidyltryptophan. Converting enzyme inhibitor. [Selection figure] None |